Dexrazoxane is administered intravenously, usually given 30 minutes before the anthracycline infusion. The dosing is typically calculated based on the dose of the anthracycline drug, often at a 10:1 ratio of dexrazoxane to doxorubicin. Proper administration and timing are crucial to maximize its protective effects while minimizing potential side effects.